Abstract
Stroke-prone spontaneously hypertensive rats (SHRSP/Izm) are salt sensitive: they develop severe hypertension and die of stroke within a short time after salt loading. We studied the role of cytochrome P-450(CYP) isoforms in the brain and the effect of clofibrate to investigate the mechanism of salt sensitive stroke-proneness in SHRSP/Izm. Male SHRSP/Izm at 9 weeks of age were fed a regular diet with or without 0.25% clofibrate and given a 1% NaCl solution for drinking water for 10 d. The expression levels of CYP4A1, 2C11, and 2C23 were measured by Western blotting. Cerebral blood flow was measured with a laser Doppler method and blood vessel diameters were measured under microscopic observation. SHRSP/Izm died within 60 d after salt loading; however, clofibrate prolonged the survival (mean life span, 33±7 vs. 215±23 d, p<0.0001) without significant attenuation of the severe hypertension. CYP4A1 and CYP2C11 expression levels were lower in SHRSP/Izm than those in age-matched male spontaneously hypertensive rats (SHR/Izm) in the cerebral cortex of SHRSP/Izm (p<0.05). No obvious change in cerebral CYP4A1 was observed in either salt-loaded SHRSP/Izm or SHR/Izm. Clofibrate significantly up-regulated the expression of cerebral CYP2C11 and significantly attenuated its salt-induced suppression (p<0.05). Additionally, clofibrate significantly increased blood vessel diameters (p<0.01) and cerebral blood flow (p<0.0001). CYP2C11 plays an important role in regulating cerebral blood flow and, as a result, in preventing stroke in the salt-sensitive stroke-prone SHRSP/Izm.
Similar content being viewed by others
Article PDF
References
Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K : Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet 1996; 13: 429–434.
Deplanque D, Gele P, Petrault O, et al: Peroxisome proliferator–activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 2003; 23: 6264–6271.
Inoue H, Jiang XF, Katayama T, Osada S, Umesono K, Namura S : Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator–activated receptor alpha in mice. Neurosci Lett 2003; 352: 203–206.
Ishizuka T, Ito O, Tan L, et al: Regulation of chytochrome P-450 4A activity by peroxisome proliferator–activated receptors in rat kidney. Hypertens Res 2003; 26: 929–936.
Fleming I : Cytochrome P450 and vascular homeostasis. Circ Res 2001; 89: 753–762.
Hoagland KM, Maier KG, Roman RJ : Conributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats. Hypertension 2003; 41: 697–702.
Muller DN, Theuer J, Shagdarsuren E, et al: A peroxisome proliferator–activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II–induced renal injury. Am J Pathol 2004; 164: 521–532.
Alkayed NJ, Birks EK, Narayanan J, Petrie KA, Kohler-Cabot AE, Harder DR : Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats. Stroke 1997; 28: 1066–1072.
The Physiological Society of Japan: Guiding principles for the care and use of animals in the field of physiological sciences. J Physiol Soc Jpn 1998; 60: Vii–Viii.
Ikeda K, Nara Y, Yamori Y : Indirect systolic and mean blood pressure determination by a new tail cuff method in spontaneously hypertensive rats. Lab Anim 1991; 25: 26–29.
Krapfenbauer K, Berger M, Lubec G, Fountoulakis M : Changes in the brain protein levels following administration of kainic acid. Electrophoresis 2001; 22: 2086–2091.
Ying CJ, Xu JW, Ikeda K, Takahashi K, Nara Y, Yamori Y : Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II–induced hyperpermeability in endothelial cells. Hypertens Res 2003; 26: 823–828.
Morii S, Ngai AC, Winn HR : Reactivity of rat pial arterioles and venules to adenosine and carbon oxide: with detailed description of the closed cranial window technique in rat. J Cereb Blood Flow Metab 1986; 6: 34–41.
Noguchi T, Ikeda K, Sasaki Y, et al: Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertens Res 2001; 24: 735–742.
Ley K, Pries AR, Gaehtgens P : Topological structure of rat mesenteric microvessels networks. Microvasc Res 1986; 32: 315–332.
Morita-Tsuzuki Y, Bouskela E, Hardebo JE : Vasomotion in the rat cerebral microcirculation recorded by laser-Doppler flowmetry. Acta Physiol Scand 1992; 146: 431–439.
Gustavsson M, Mallard C, Vannucci SJ, Wilson MA, Johnston MV, Hagberg H : Vascular response to hypoxic preconditioning in the immature brain. J Cereb Blood Flow Metab 2007; 27: 928–938.
Moffat MP, Ward CA, Bend JR, Mock T, Farhangkhoee P, Karmazyn M : Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes. Am J Physiol 1993; 264: H1154–H1160.
Alkayed NJ, Birks EK, Hudetz AG, Roman RJ, Henderson L, Harder DR : Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol 1996; 271: 1541–1546.
Alkayed NJ, Goyagi T, Joh HD, et al: Neuroprotection and P450 2C11 upregulation after experimental transientischemic attack. Stroke 2002; 33: 1677–1684.
Yamori Y, Horie R : Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 1977; 8: 456–461.
Mies G, Hermann D, Ganten U, Hossman KA : Hemodynamics and metabolism in stroke-prone spontaneously hypertensive rats before manifestation of brain infarcts. J Cereb Blood Flow Metab 1999; 19: 1238–1246.
Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthes SC : Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol 1990; 259: 1171–1177.
Zhao X, Quigley JE, Yuan J, Wang MH, Zhou Y, Imig JD : PPAR-alpha activator fenofibrate increases renal CYPderived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats. Am J Physiol Heart Circ Physiol 2006; 290: H2187–H2195.
Bordet R, Ouk T, Petrault O, et al: PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans 2006; 34: 1341–1346.
Atkins D, Psaty BM, Koepsell TD, Longstreth WT Jr, Larson EB : Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials. Ann Intern Med 1993; 119: 136–145.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ying, CJ., Noguchi, T., Aso, H. et al. The Role of Cytochrome P-450 in Salt-Sensitive Stroke in Stroke-Prone Spontaneously Hypertensive Rats. Hypertens Res 31, 1821–1827 (2008). https://doi.org/10.1291/hypres.31.1821
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1821